3D Global Biotech Inc. (TPEX:6808)

3D Global Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	67.43	21.82	15.53	20.37	8.43	8.71
Short-Term Investments	274	144.2	192.9	212.8	268.3	288.1
Cash & Short-Term Investments	341.43	166.02	208.43	233.17	276.73	296.81
Cash Growth	82.38%	-20.35%	-10.61%	-15.74%	-6.77%	57.36%
Accounts Receivable	2.14	1.35	1.09	1.23	1.61	2.17
Other Receivables	0.52	0.59	0.44	0.41	0.67	1
Receivables	2.66	1.94	1.53	1.64	2.28	3.17
Inventory	42.73	3.6	3.37	0.88	1.14	1.18
Other Current Assets	0	4.12	2.68	4.15	1.08	1
Total Current Assets	390.83	175.67	216.01	239.85	281.23	302.16
Property, Plant & Equipment	12.06	13.15	21.02	28.17	28.9	14.58
Other Intangible Assets	94.96	102.29	117.09	152.3	168.62	184.96
Long-Term Deferred Tax Assets	16.72	16.27	15.31	3.2	3.16	3.81
Other Long-Term Assets	1.04	16.77	1.84	0.99	0.67	0.67
Total Assets	515.61	324.15	371.26	424.52	482.57	506.18
Accounts Payable	39.17	3.33	2.22	0.67	0.93	1.15
Accrued Expenses	7.04	7.91	7.61	6.35	5.31	4.65
Current Portion of Leases	6.1	6.3	6.37	5.5	4.09	2.68
Current Unearned Revenue	3.45	7.31	2.22	-	-	-
Other Current Liabilities	1.79	1.65	1.74	2.44	1.57	2.31
Total Current Liabilities	57.54	26.49	20.17	14.95	11.9	10.78
Long-Term Leases	1.02	4.08	10.38	15.81	16.7	-
Long-Term Deferred Tax Liabilities	-	-	-	3.94	5.16	6.38
Other Long-Term Liabilities	-	0.11	0.11	0.11	-	-
Total Liabilities	58.56	30.68	30.66	34.81	33.75	17.16
Common Stock	668.09	568.09	557.4	539.7	539.7	532.5
Additional Paid-In Capital	65.87	1.22	2.08	1.8	1.61	98.59
Retained Earnings	-276.92	-275.84	-218.88	-151.79	-92.49	-142.07
Shareholders' Equity	457.04	293.47	340.6	389.71	448.82	489.02
Total Liabilities & Equity	515.61	324.15	371.26	424.52	482.57	506.18
Total Debt	7.12	10.38	16.75	21.31	20.78	2.68
Net Cash (Debt)	334.31	155.64	191.68	211.87	255.95	294.14
Net Cash Growth	92.54%	-18.80%	-9.53%	-17.22%	-12.98%	61.83%
Net Cash Per Share	5.57	2.77	3.49	3.93	4.78	5.82
Filing Date Shares Outstanding	66.81	56.81	55.74	53.97	53.97	53.97
Total Common Shares Outstanding	66.81	56.81	55.74	53.97	53.97	53.97
Working Capital	333.29	149.17	195.84	224.9	269.34	291.38
Book Value Per Share	6.84	5.17	6.11	7.22	8.32	9.06
Tangible Book Value	362.09	191.18	223.52	237.41	280.2	304.06
Tangible Book Value Per Share	5.42	3.37	4.01	4.40	5.19	5.63
Machinery	16.76	14.61	14.38	13.77	10.94	10.75
Leasehold Improvements	13.15	12.57	12.57	12.57	12.57	12.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.